Current Net Margin
-1779.03%
CG Oncology, Inc. Common stock currently has a net profit margin of -1779.03%.
Financial Fundamentals
CGON • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.04 | -1779.03% | ▲85051 |
| 2025-09-30 | 0.00 | -0.04 | -2629.53% | — |
| 2025-06-30 | 0.00 | -0.04 | — | — |
| 2025-03-31 | 0.00 | -0.03 | -66253.85% | ▼5928060 |
| 2024-12-31 | 0.00 | -0.03 | -6973.25% | ▲4048024 |
| 2024-09-30 | 0.00 | -0.02 | -47453.49% | ▼3042466 |
| 2024-06-30 | 0.00 | -0.02 | -17028.83% | ▼1382807 |
| 2024-03-31 | 0.00 | -0.02 | -3200.76% | ▲160839924 |
| 2023-12-31 | 0.00 | -0.02 | -1611600.00% | ▼148084444 |
| 2023-09-30 | 0.00 | -0.01 | -130755.56% | — |
| 2023-06-30 | 0.00 | -0.01 | — | — |
| 2023-03-31 | 0.00 | -0.01 | -4467.53% | — |
| 2022-12-31 | 0.00 | -0.01 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.